New Treatment Approved for Prostate Cancer That Resists Hormone Therapy

Erleada (apalutamide) has been approved by the U.S. Food and Drug Administration to treat non-spreading prostate cancer that continues to grow despite hormone therapy.

Prostate cancer is the second-most-common form of the disease among men in the United States, the National Cancer Institute says. More than 161,000 men were diagnosed in 2017, and nearly 27,000 men were projected to die of prostate cancer last year, the NCI estimates.

Erleada is designed to block the effects of a type of tumor-spurring hormone known as an androgen. An example of an androgen is the male hormone testosterone, the FDA said in a media release.

The drug was evaluated in clinical studies involving more than 1,200 participants with this type of prostate cancer. Average survival before the tumor spread was 40.5 months among men who took Erleada, compared to 16.2 months among those who took a placebo.

The most common side effects of the drug included fatigue, high blood pressure, rash, diarrhea, nausea, weight loss, joint pain, hot flushes and loss of appetite. More serious adverse reactions included falls, bone fractures and seizures, the FDA said.

Erleada is produced by Belgium-based Janssen Pharmaceutical Companies.

More information

Visit the FDA to find out more.


Copyright © 2013-2018 HealthDay. All rights reserved.

Mental Health Does Not Come With A Manual, It Comes With Friends & Family Support That Never Gives Up!
Join now

Related Content

Freedom From OCD: An Original Series on Obsessive-Compulsive Disorder
Freedom From OCD: An Original Series on Obsessive-Compulsive Disorder

It is estimated over 1.2% of the adult population wrestles with Obsessive-Compul...

Read more
Freedom From OCD - Official Trailer
Freedom From OCD - Official Trailer

An original 6-episode series on obsessive-compulsive disorder, available instant...

Read more
A Young Mother's Addiction Led To Death & Her Obituary Struck An International Chord
A Young Mother's Addiction Led To Death & Her Obituary Struck An International Chord

Madelyn Ellen Linsenmeir died on Sunday, October 7. While her death was unexpect...

Read more
Why Are Children In Class Being Wrongly Labelled As Having ADHD So Frequently?
Why Are Children In Class Being Wrongly Labelled As Having ADHD So Frequently?

Parents worried about their child falling behind academically because they are b...

Read more
The Real Causes Of Anxiety & Depression Might Not Be What You Think
The Real Causes Of Anxiety & Depression Might Not Be What You Think

Across the Western world today, if you are depressed or anxious and you go to yo...

Read more
Companies Are Opening Their Doors To Talent With Autism
Companies Are Opening Their Doors To Talent With Autism

Twenty-seven-year-old Christopher Pauley thought he had it all figured out when ...

Read more